Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
US7897610B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 5, 2003 |
| Grant date | Mar 1, 2011 |
| Priority date | — |
| Expiry date | Dec 21, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D455/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of benzo[c]quinolizinium derivatives for treating diseases that are linked to smooth muscle cell constriction, such as hypertension and asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.